Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald R Nixon

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Cataract and Refractive Surgery|December 25, 2004
In vivo digital imaging of the square-edged barrier effect of a silicone intraocular lensDonald R Nixon
Journal of Cataract and Refractive Surgery|February 16, 2010
Preoperative cataract grading by Scheimpflug imaging and effect on operative fluidics and phacoemulsification energyDonald R Nixon
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|September 28, 2013
A randomized, prospective study of bimatoprost 0.01% or travoprost/timolol in patients previously treated with latanoprost and timolol to reduce intraocular pressureDonald R Nixon
Clinical Ophthalmology (Auckland, N.Z.)|April 28, 2021
Visual Function for Driving in Diabetic Macular Edema and Retinal Vein Occlusion Post-Stabilization with Anti-Vascular Endothelial Growth FactorDonald R Nixon, Nicholas Flinn
Clinical Ophthalmology (Auckland, N.Z.)|February 7, 2018
Evaluation of contrast sensitivity and other visual function outcomes in diabetic macular edema patients following treatment switch to aflibercept from ranibizumabDonald R Nixon, Nicholas Ap Flinn
Clinical Ophthalmology (Auckland, N.Z.)|May 2, 2017
Evaluation of contrast sensitivity and other visual function outcomes in neovascular age-related macular degeneration patients after treatment switch to aflibercept from ranibizumabDonald R Nixon, Nicholas Ap Flinn
Clinical Ophthalmology (Auckland, N.Z.)|November 19, 2021
Contrast Sensitivity Changes in Center Involving Diabetic Macular Edema Treated with AfliberceptDonald R Nixon, Nicholas Flinn, Claudia Enderlein
Journal of Cataract and Refractive Surgery|August 20, 2014
Microincisions in cataract surgerySteven Dewey, George Beiko, Rosa Braga-Mele, et al.
Current Medical Research and Opinion|May 30, 2009
Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapyDonald R Nixon, David B Yan, Jean-Pierre Chartrand, et al.
Clinical Ophthalmology (Auckland, N.Z.)|July 28, 2011
Twelve-week, randomized, multicenter study comparing a fixed combination of brimonidine-timolol with timolol as therapy adjunctive to latanoprostRobert D Fechtner, Paul Harasymowycz, Donald R Nixon, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Cataract and Refractive Surgery|December 25, 2004
In vivo digital imaging of the square-edged barrier effect of a silicone intraocular lensDonald R Nixon
Journal of Cataract and Refractive Surgery|February 16, 2010
Preoperative cataract grading by Scheimpflug imaging and effect on operative fluidics and phacoemulsification energyDonald R Nixon
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|September 28, 2013
A randomized, prospective study of bimatoprost 0.01% or travoprost/timolol in patients previously treated with latanoprost and timolol to reduce intraocular pressureDonald R Nixon
Clinical Ophthalmology (Auckland, N.Z.)|April 28, 2021
Visual Function for Driving in Diabetic Macular Edema and Retinal Vein Occlusion Post-Stabilization with Anti-Vascular Endothelial Growth FactorDonald R Nixon, Nicholas Flinn
Clinical Ophthalmology (Auckland, N.Z.)|February 7, 2018
Evaluation of contrast sensitivity and other visual function outcomes in diabetic macular edema patients following treatment switch to aflibercept from ranibizumabDonald R Nixon, Nicholas Ap Flinn
Clinical Ophthalmology (Auckland, N.Z.)|May 2, 2017
Evaluation of contrast sensitivity and other visual function outcomes in neovascular age-related macular degeneration patients after treatment switch to aflibercept from ranibizumabDonald R Nixon, Nicholas Ap Flinn
Clinical Ophthalmology (Auckland, N.Z.)|November 19, 2021
Contrast Sensitivity Changes in Center Involving Diabetic Macular Edema Treated with AfliberceptDonald R Nixon, Nicholas Flinn, Claudia Enderlein
Journal of Cataract and Refractive Surgery|August 20, 2014
Microincisions in cataract surgerySteven Dewey, George Beiko, Rosa Braga-Mele, et al.
Current Medical Research and Opinion|May 30, 2009
Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapyDonald R Nixon, David B Yan, Jean-Pierre Chartrand, et al.
Clinical Ophthalmology (Auckland, N.Z.)|July 28, 2011
Twelve-week, randomized, multicenter study comparing a fixed combination of brimonidine-timolol with timolol as therapy adjunctive to latanoprostRobert D Fechtner, Paul Harasymowycz, Donald R Nixon, et al.
Pageof 2